Your browser doesn't support javascript.
loading
Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry.
Martinez-Morilla, Sandra; Villarroel-Espindola, Franz; Wong, Pok Fai; Toki, Maria I; Aung, Thazin Nwe; Pelekanou, Vasiliki; Bourke-Martin, Brian; Schalper, Kurt A; Kluger, Harriet M; Rimm, David L.
Afiliação
  • Martinez-Morilla S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Villarroel-Espindola F; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Wong PF; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Toki MI; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Aung TN; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Pelekanou V; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Bourke-Martin B; Navigate BioPharma Services, Inc., Carlsbad, California.
  • Schalper KA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Kluger HM; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Rimm DL; Department of Pathology, Yale School of Medicine, New Haven, Connecticut. david.rimm@yale.edu.
Clin Cancer Res ; 27(7): 1987-1996, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33504554

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citometria por Imagem / Microambiente Tumoral / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citometria por Imagem / Microambiente Tumoral / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article